At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.

Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.

A randomized, double-blind, placebo-controlled trial in reproductive-age women found that 8 weeks of standardized shatavari extract supplementation was associated with improvements in sexual function, vaginal moisture, fatigue, and sleep disturbance.

Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.